Calcitonin gene related peptide (CGRP) inhibits norepinephrine induced apoptosis in cultured rat cardiomyocytes not via PKA or PKC pathways

Evidence showed overrelease of norepinephrine can induce apoptosis in ventricle myocytes. Calcitonin gene related peptide and norepinephrine could be simultaneously up-regulated in early time of acute myocardial ischemia, suggesting a co-participation of calcitonin gene related peptide and norepinep...

Full description

Saved in:
Bibliographic Details
Published in:Neuroscience letters 2010-09, Vol.482 (2), p.163-166
Main Authors: Zhao, Fu-Ping, Guo, Zheng, Wang, Peng-Fei
Format: Article
Language:English
Subjects:
Animals
Animals, Newborn
Apoptosis
Biological and medical sciences
Calcitonin gene related peptide
Calcitonin Gene-Related Peptide - pharmacology
Calcitonin Gene-Related Peptide - physiology
cAMP-dependent protein kinase
Cells, Cultured
CGRP
Cyclic AMP-Dependent Protein Kinases - physiology
Fundamental and applied biological sciences. Psychology
Myocytes, Cardiac - cytology
Myocytes, Cardiac - drug effects
Norepinephrine
Norepinephrine - pharmacology
Norepinephrine - physiology
Protein Kinase C - physiology
Rats
Rats, Sprague-Dawley
Signal Transduction
Vertebrates: nervous system and sense organs
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Evidence showed overrelease of norepinephrine can induce apoptosis in ventricle myocytes. Calcitonin gene related peptide and norepinephrine could be simultaneously up-regulated in early time of acute myocardial ischemia, suggesting a co-participation of calcitonin gene related peptide and norepinephrine in the pathology. In this study, we investigated a potential anti-apoptotic effect of calcitonin gene related peptide on myocardial apoptosis induced by norepinephrine and its link with the protein kinase A (PKA) or protein kinase C (PKC) pathway in cultured neonatal rat cardiomyocytes. Cultured cardiomyocytes were exposed to one of the treatments, separately: (1) 3 ml DMEM culture medium, (2) norepinephrine (10 −5 mol/l), (3) H89 (3 × 10 −5 mol/l), a specific PKA inhibitor, with norepinephrine (10 −5 mol/l), (4) calcitonin gene related peptide at a range of concentrations (10 −9 mol/l, 10 −8 mol/l and 10 −7 mol/l) with norepinephrine (10 −5 mol/l) and (5) calcitonin gene related peptide (10 −8 mol/l) with norepinephrine (10 −5 mol/l) + CGRP 8–7 (10 −7 mol/l), a specific antagonist of calcitonin gene related peptide receptor. Then, apoptosis rate and the activity of PKA and PKC were examined. The dose of norepinephrine induced a marked increase in apoptosis of the myocytes (31 ± 2%), compared to the control (17 ± 4%, p < 0.05). The pro-apoptotic effect of norepinephrine was attenuated by H89 (3 × 10 −5 mol/l) or by calcitonin gene related peptide which could be completely reversed by CGRP 8–37. The activities of PKA and PKC were increased by norepinephrine but no difference in the activities of PKA and PKC was detected in the presence and absence of co-treatment with calcitonin gene related peptide (10 −8 mol/l). Calcitonin gene related peptide inhibits norepinephrine induced apoptosis in cultured cardiomyocytes, which is mediated by CGRP receptor but unlikely to be mediated by PKA or PKC pathway.
ISSN:0304-3940
1872-7972
DOI:10.1016/j.neulet.2010.07.025